Research ArticleRESEARCH

Indomethacin-loaded Poly(butylcyanoacrylate) Nanoparticles: Preparation and Characterization

Haiyan Liu and Jinchun Chen
PDA Journal of Pharmaceutical Science and Technology May 2009, 63 (3) 207-216;

References

  1. 1.↵
    1. Hubbell J. A.
    Materials science. Enhancing drug function. Science 2003, 300 ( 5619), 595– 596.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Panyam J.,
    2. Labhasetwar V.
    Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 2003, 55 ( 3), 329– 347.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Soppimath K. S.,
    2. Aminabhavi T. M.,
    3. Kulkarni A. R.,
    4. Rudzinski W. E.
    Biodegradable polymeric nanoparticles as drug delivery devices. J. Controlled Release 2001, 70 ( 1–2), 1– 20.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Nair L. S.,
    2. Laurencin C. T.
    Biodegradable polymers as biomaterials. Pro Polymer Sci. 2007, 32( 8), 762– 798.
    OpenUrl
  5. 5.↵
    1. O'Sullivan C.,
    2. Birkinshaw C.
    Hydrolysis of poly(n-butyl-cyanoacrylate) nanoparticles using esterase. Polym. Degrad. Stabil. 2002, 78 ( 1), 7– 15.
    OpenUrl
  6. 6.↵
    1. Couvreur P.,
    2. Kante B.,
    3. Roland M.,
    4. Guiot P.,
    5. Bauduin P.,
    6. Speiser P.
    Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J. Pharm. Pharmacol. 1979, 31( 5), 331– 332.
    OpenUrlPubMedWeb of Science
  7. 7.↵
    1. Couvreur P.,
    2. Vauthier C.
    Polyalkylcyanoacrylate nanoparticles as drug carriers: present state and perspectives. J. Controlled Release 1991, 17 ( 2), 187– 198.
    OpenUrlCrossRef
  8. 8.↵
    1. Lherm C.,
    2. Müller R. H.,
    3. Puisieux F.,
    4. Couvreur P.
    Alkylcyanoacrylate drug carriers. II. Cytotoxicity of cyanoacrylate nanoprticles with different alkyl chain length. Int. J. Pharm. 1992, 84 ( 1), 13– 22.
    OpenUrl
  9. 9.↵
    1. Vauthier C.,
    2. Dubernet C.,
    3. Fattal E.,
    4. Pinto-Alphandary H.,
    5. Couvreur P.
    Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv. Drug Deliv. Rev. 2003, 55 ( 4), 519– 548.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Rusu D.,
    2. Cimpoiu C.,
    3. Hodisan T.
    The control over the new obtaining procedeum of indomethacin. J. Pharm. Biomed. Anal. 1998, 17( 3), 409– 413.
    OpenUrlPubMed
  11. 11.↵
    1. Stewart R.,
    2. Grosserode R.,
    3. Cheetham J. K.,
    4. Rosenthal A.
    Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced mitosis during cataract surgery. Clin. Ther. 1999, 21 ( 4), 723– 732.
    OpenUrlPubMed
  12. 12.↵
    1. Mentes J.,
    2. Erakgün T.,
    3. Afrashi F.,
    4. Kerci G.
    Incidence of cystoids macular edema after uncomplicated phacoemulsification. Ophthalmologica 2003, 217 ( 6), 408– 412.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Carless J. E.,
    2. Rowe J. S.
    The use of Critical Flicker Fusion frequency test for evaluating some central nervous effects of two indomethacin formulations. J. Pharm. Pharmacol. 1981, 33 ( 6), 336– 337.
    OpenUrlPubMed
  14. 14.↵
    1. Eis M. J.,
    2. Watkins B. M.,
    3. Philip A.,
    4. Welling R. E.
    Non-steroidal-induced benign structures of colon: a case report and review of the literature. Am. J. Gastroenterol. 1998, 93( 1), 120– 121.
    OpenUrlPubMed
  15. 15.↵
    1. Guterres S. S.,
    2. Weiss V.,
    3. de Lucca Freitas L.,
    4. Pohlmann A. R.
    Influence of benzyl benzoate as oil core on the physicochemical properties of spray dried powders from polymeric nanocapsules containing indomethacin. Drug Deliv. 2000, 7 ( 4), 195– 199.
    OpenUrlPubMed
  16. 16.↵
    1. Kim S. Y.,
    2. Lee Y. M.,
    3. Kang J. S.
    Indomethacin-loaded methoxy poly(ethylene glycol)/poly(D,L-lactide) amphiphilic diblock copolymeric nanospheres: pharmacokinetic and toxicity studies in rodents. J. Biomed. Mater. Res. A 2005, 74 ( 4), 581– 590.
    OpenUrlPubMed
  17. 17.↵
    1. Kim I. S.,
    2. Jeong Y. I.,
    3. Cho C. S.,
    4. Kim S. H.
    Core-shell type polymeric nanoparticles composed of poly(l-lactic acid) and poly(N-isopropylacrylamide). Int. J. Pharm. 2000, 211( 1–2), 1– 8.
    OpenUrlPubMed
  18. 18.↵
    1. Longuemard P.,
    2. Jbilou M.,
    3. Guyot-Hermann A.-M.,
    4. Guyot J.-C.
    Ground and native crystals: comparison of compression capacity and dissolution rate. Int. J. Pharm. 1998, 170 ( 1), 51– 61.
    OpenUrl
  19. 19.↵
    1. Ponchel G.,
    2. Montisci M.-J.,
    3. Dembri A.,
    4. Durrer C.,
    5. Duchêne D.
    Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract: bioadhesion: state-of-the-art and perspectives. Eur. J. Pharm. Biopharm. 1997, 44 ( 1), 25– 31.
    OpenUrl
  20. 20.↵
    1. Xia H. S.,
    2. Wang Q.
    Synthesis and characterization of conductive polyaniline nanoparticles through ultrasonic assisted inverse microemulsion polymerization. J. Nanopart. Res. 2001, 3 ( 5–6), 399– 409.
    OpenUrl
  21. 21.↵
    1. Fawaz F.,
    2. Guyot M.,
    3. Lagueny A. M.,
    4. Devissaguet J. P.
    Ciprofloxacin-loaded polyisobutylcyanoacrylate nanoparticles: preparation and characterization. Int. J. Pharm. 1997, 154 ( 2), 191– 203.
    OpenUrl
  22. 22.↵
    1. Gupta A. K.,
    2. Gupta M.
    Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26 ( 18), 3995– 4021.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Chouinard F.,
    2. Buczkowski S.,
    3. Lenaerts V.
    Poly(alkylcyanoacrylate) nanocapsules: physicochemical characterization and mechanism of formation. Pharm. Res. 1994, 11 ( 6), 869– 874.
    OpenUrlPubMed
  24. 24.↵
    1. Prot O.,
    2. Benoit E.,
    3. Maincent P.,
    4. Bessiere J.
    Adsorption of beta-blockers onto poly(isobutylcyanoacrylate) nanoparticles: adsorption model and dielectric interpretation. J. Colloid. Interface Sci. 1996, 184 ( 1), 251– 258.
    OpenUrlPubMed
  25. 25.↵
    1. Brasseur N.,
    2. Brault D.,
    3. Couvreur P.
    Adsorption of hematoporphyrin onto polyalkylcyanoacrylate nanoparticles: carrier capacity and drug release. Int. J. Pharm. 1991, 70 ( 1–2), 129– 135.
    OpenUrl
  26. 26.↵
    1. Davis S. S.,
    2. Illum L.,
    3. McVie J. G.,
    4. Tomlinson E.
    Microsphere and Drug Therapy, 1st ed.; Elsevier Science Publishers: New York, 1984; p 103.
  27. 27.↵
    1. Douglas S. J.,
    2. Illum L.,
    3. Davis S. S.,
    4. Kreuter J.
    Particle size and size distribution of poly(butyl 2-cyanoacrylate) nanoparticles. II. Influence of stabilizers. J. Colloid. Interface Sci. 1985, 103 ( 1), 154– 163.
    OpenUrl
  28. 28.↵
    1. Douglas S. J.,
    2. Davis S. S.
    Molecular weights of poly (butyl 2-cyanoacrylate) produced during nanoparticle formation. Br. Polymer J. 1985, 17 ( 4), 339– 342.
    OpenUrl
  29. 29.↵
    1. Kreuter J.
    Colloidal Drug Delivery Systems; Marcel Dekker Inc.: New York, 1994; Vol. 66, p 219.
    OpenUrl
  30. 30.↵
    1. Mitra A.,
    2. Lin S. J.
    Effect of surfactant on fabrication and characterization of paclitaxel-loaded polybutylcyanoacrylate nanoparticulate delivery systems. J. Pharm. Pharmacol. 2003, 55 ( 7), 895– 902.
    OpenUrlPubMed
  31. 31.↵
    1. Feng S. S.,
    2. Huang G.
    Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers. J. Controlled Release 2001, 71 ( 1), 53– 69.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Van Snick K.,
    2. Couvreur P.,
    3. Christiaens-Leyh D.,
    4. Roland M.
    Molecular weights of free and drug-loaded nanoparticles. Pharm. Res. 1985, 2 ( 1), 36– 41.
    OpenUrl
  33. 33.↵
    1. Arias J. L.,
    2. Gallardo V.,
    3. Ruiz M. A.,
    4. Delgado A. V.
    Ftorafur loading and controlled release from poly(ethyl-2-cyanoacrylate) and poly(butylcyanoacrylate) nanospheres. Int. J. Pharm. 2007, 337 ( 1–2), 282– 290.
    OpenUrlPubMed
  34. 34.↵
    1. Lenaerts V.,
    2. Couvreur P.,
    3. Christiaens-Leyh D.,
    4. Joiris E.,
    5. Roland M.,
    6. Rollman B.,
    7. Speiser P.
    Degradation of poly(isobutyl cyanoacrylate) nanoparticles. Biomaterials 1984, 5( 2), 65– 68.
    OpenUrlPubMed
  35. 35.↵
    1. Huang C.-Y.,
    2. Lee Y.-D.
    Core-shell type of nanoparticles composed of poly[(n-butyl cyanoacrylate)-co-(2-octyl cyanoacrylate)] copolymers for drug delivery application: synthesis, characterization and in vitro degradation. Int. J. Pharm. 2006, 325( 1–2), 132– 139.
    OpenUrlPubMed
Back to top

In This Issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Indomethacin-loaded Poly(butylcyanoacrylate) Nanoparticles: Preparation and Characterization
Haiyan Liu, Jinchun Chen
PDA Journal of Pharmaceutical Science and Technology May 2009, 63 (3) 207-216;
Twitter logo Facebook logo Mendeley logo

Jump to section